← Back to Search

Financial Incentives for Glaucoma Care Adherence

N/A

Waitlist Available

Led By Christopher A Girkin, MD, MSPH

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Anyone ≥ 18 years with a glaucoma associated diagnosis

Non-Hispanic white ≥50 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the time frame will be from baseline through 3 years of recruitment in the study.

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new way to detect and manage glaucoma, using telemedicine to improve access to care for a vulnerable population.

Who is the study for?

This trial is for adults over 18 with glaucoma-related diagnoses, diabetes, or a family history of glaucoma. It focuses on African Americans and Hispanics over 40, and non-Hispanic whites over 50. Participants must speak and understand English. There are no specific exclusion criteria.

What is being tested?

The study is testing if giving people money can make them more likely to go to eye care appointments after being referred for conditions like cataract, glaucoma, diabetic retinopathy, etc., compared to not offering money.

What are the potential side effects?

Since this trial involves financial incentives rather than medical treatments or drugs, there are no direct physical side effects associated with the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older and have been diagnosed with glaucoma.

Select...

I am a non-Hispanic white person aged 50 or older.

Select...

I am 18 or older and have diabetes.

Select...

I can speak and understand English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the time frame will be from baseline through 3 years of recruitment in the study.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the time frame will be from baseline through 3 years of recruitment in the study.

This trial's timeline: 3 weeks for screening, Varies for treatment, and the time frame will be from baseline through 3 years of recruitment in the study. for reporting.